EDSP Phase I: Challenges and Lessons Learned
description
Transcript of EDSP Phase I: Challenges and Lessons Learned
![Page 1: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/1.jpg)
2010 Endocrine Workshop: EDSP Compliance
December 13, 2010
steptoe.com
EDSP Phase I: Challenges and Lessons LearnedErik R. JanusTechnical & Regulatory Analyst
![Page 2: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/2.jpg)
2
This morning’s program
8:45 - 11:45 am: Morning Session
EDSP Phase I: Challenges and Lessons Learned 8:45 - 9:00 Erik Janus, Steptoe & Johnson LLP (Session Chair)
Introduction/Overview 9:00 - 9:15 Erik Janus, Steptoe & Johnson LLP
Procedural and Legal Issues 9:15 - 9:50 Terry Quill, Quill Law Group
Update/Status on Other Scientifically Relevant Info 9:50 – 10:30Barbara Neal, Exponent
Morning Break & Exhibit Viewing 10:30 - 10:45
Test Guidelines and Guideline Modifications 10:45 - 11:25 Ellen Mihaich, Environmental and Regulatory Resources
Discussion / Audience Q&A / Introduction of Exhibitors
![Page 3: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/3.jpg)
3
EDSP Phase I: Challenges and Lessons Learned
EDSP Tiered Approach & Initial Policy Decisions
Test Method Development & Validation Stakeholder Outreach & Communication Harmonization with Other Regulatory
Programs Effects of “Aging”
![Page 4: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/4.jpg)
4
EDSP as a novel program
Developing and validating a new chemical screening and testing program is very resource intensive and requires effective stakeholder input as well as dedicated leadership throughout the process
The EDSP policy microcosm has highlighted some key technical and regulatory issues which continue to require challenging solutions
![Page 5: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/5.jpg)
5
Technical Challenges
OSRI: acceptance of info, processing of info, rendering determinations from info
WoE: a priori hypothesis testing and/or decision-making frameworks versus “learning by doing”
Test Guideline validation: interlaboratory performance, industry standards, implementation in different countries
![Page 6: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/6.jpg)
6
Regulatory & Policy Challenges
Stakeholder input: WoE guidance, peer review of TGs, OSRI guidance
Harmonization with other legislative initiatives
Inerts, drinking water compound order recipient identification and data compensation
Public communication of scientific and regulatory program needs
![Page 7: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/7.jpg)
7
EDSP Tiered Approach
The “checklist approach” is outdated! Current science has moved beyond
inflexible “one size fits all” testing batteries that cannot incorporate 21st century tox methods and ideas
Final process is not “quick, simple and cheap”
Selection of chemicals is still on potential for exposure, not toxicity
![Page 8: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/8.jpg)
8
The clock keeps ticking …
Perhaps most importantly, the EDSP timeline keeps moving forward while major issues remain unresolved: Standard Evaluation Procedures Weight of Evidence Methodology OSRI Determinations
Over 200 chemicals identified for screening – almost 140 are pesticide actives ALL pesticides must be tested per FQPA Over 1000 “common chemical names” in NPIRS
![Page 9: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/9.jpg)
9
Test Development & Validation
Cost and time estimates were quite low – even lower when paired with high rejection rate of OSRI and overly prescriptive Test Guidelines
Tension between modern comprehensive and redundant screening battery and stakeholder and procedural issues
Validation of battery as a whole was not performed
Interpretation of battery suffers from lack of detailed guidance
Lack of core set of test compounds and designated positive and negative controls
![Page 10: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/10.jpg)
10
Stakeholder Outreach & Communication
Highly visible, politically charged Susceptible to the “problem child of the
week” response Very long development timeline Rapidly changing knowledge Change of administration and
“preferred stakeholders”
![Page 11: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/11.jpg)
11
Harmonization with Other Regulatory Programs
TSCA (or whatever the reform will look like)
OECD endocrine framework European legislation: REACh, plant
protection products, biocides, new drugs, cosmetics
Safe Drinking Water Act California Green Chemistry program
![Page 12: EDSP Phase I: Challenges and Lessons Learned](https://reader034.fdocuments.in/reader034/viewer/2022052401/568146fb550346895db4341c/html5/thumbnails/12.jpg)
12
Effects of “Aging”
Original FQPA mandate = 1996! The numbers game: 2 centuries, 3 Presidents,
5 EPA Administrators, 8 Sessions of Congress, 14 calendar years of Congressional appropriations (up to $10 million per year?)
Leadership issues Has this impacted the timeline or vice versa? Who is in charge? (OSCP vs OPP)
Forward progress has been more stochastic than sustained - often driven by external, non-scientific issues
Science has rapidly outpaced regulation